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Smoking mice from both genotypes showed disseminated foci of emphysema and large areas of goblet cell
metaplasia in bronchial and bronchiolar epithelium. Morphometric evaluation of lung changes and lung
elastin determination conﬁrmed that mice from both genotypes showed the same degree of emphyse-
matous lesions. Thus, cigarette smoke exposure in the presence of severe reduction in number and
function of peripheral T cells does not inﬂuence the development of pulmonary changes induced by
cigarette smoke. The data obtained suggest that innate immunity is a leading actor in the early devel-
opment of pulmonary changes in smoking mice and that the adaptive immune response may play a role at
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Disclosures: None declared.Cigarette smoke (CS) is considered to be the main causative
factor of chronic obstructive pulmonary disease (COPD) in
humans.1,2 The pathogenesis of this disease is still subject to
debate, and several mechanisms are involved in the devel-
opment of parenchymal and airway lesions that characterize
COPD. These mechanisms include protease/antiprotease
and oxidant/antioxidant imbalances, increased rate of epithe-
lial cell apoptosis, and abnormal innate or adaptive immune
responses.3
For innate and adaptive immune mechanisms, many ele-
ments of both types of response are abnormal in COPD.4,5
Although the innate immune response was long considered
important in the pathogenesis of COPD, some evidence sup-
ports a role of the acquired response that requires the prolif-
eration of T cells.6Whether and howT cells actually contribute
to COPD pathogenesis, however, remains undeﬁned.stigative Pathology. Published by Elsevier Inc
Y-NC-ND license (http://creativecommons.orgTo investigate the pathogenic role of adaptive immune
responses that require the proliferation of T cells in the
development of smoke-induced lung changes that resemble
COPD in humans, genetically engineered mice knocked out
of the Lck gene were used.
The protein Lck (p56Lck) is a Src family tyrosine kinase
expressed at all stages of thymocyte development and is
required for the maturation of T cells.7,8 The targeted
disruption of the Lck gene results in a severe block in
thymocyte maturation with a substantial reduction in the
development of CD4þCD8þ thymocytes, severe reduction of.
/licenses/by-nc-nd/4.0).
T Lymphocytes and Emphysema Developmentperipheral T cells,9,10 and disruption of T-cell receptor (TCR)
signaling with a defective function of T-cell responses.11
Here, we report that the combination of chronic CS
exposure in the presence of a severe reduction of T cells
results in the development of lung emphysema and goblet
cell metaplasia. Reduced T-cell response in smoking mice
results in chronic inﬂammation with the presence of a large
number of neutrophils and activated macrophages.
These ﬁndings provide evidence that T lymphocytes play
a trivial role in the development of smoking-induced lung
emphysema and airway remodeling in smoking mice.
Materials and Methods
Mice
Wild-type (WT; C57 Bl/6J) and Lck-deﬁcient (Lck/ with
C57 Bl/6J background) mice were initially obtained from
The Jackson Laboratory (Bar Harbor, ME). The colonies
were expanded at Charles River’ husbandries (Calco, Italy)
and then supplied to Siena University animal house. The
mice were housed in an environment controlled for light
(7 AM to 7 PM) and temperature (18C to 22C), and food
(Mucedola Global Diet 2018; Harlan, Correzzana, Italy) and
water were provided for consumption ad libitum. All animal
experiments were conducted in conformity with the Guiding
Principles for Research Involving Animals and Human
Beings12 and were approved by the Local Ethics Committee
of the University of Siena.
Exposure to CS
Male mice (at 6 to 8 weeks of age) from each experimental
group were exposed to the smoke of three cigarettes/day, 5
days/week for 7 months (Virginia ﬁlter cigarettes, 12 mg of
tar and 0.9 mg of nicotine) in especially designed cages,
according to Cavarra et al.13 Control mice were exposed to
air under the same conditions (sham-exposed). The con-
centration of smoke/air mixture was maintained at 140  12
mg/m3 total suspended particulate. Air-control and smoking
mice were anesthetized with sodium pentobarbital and
sacriﬁced by severing the abdominal aorta.
Determination of Lymphocyte T Subsets by
Fluorescence Activated Cell Sorter
Peripheral blood was obtained by cardiac puncture with
the use of heparin as anticoagulant and subjected to ﬂow
cytometry after hypotonic lysis of red blood cells. Fluores-
cein isothiocyanate-conjugated anti-CD4 monoclonal anti-
body (mAb) and phosphatidylethanolamine-conjugated
anti-CD8 mAb (BD Biosciences, San Jose, CA) were used.
Flow cytometry was performed on a GUAVA EasyCyte
6-2L ﬂow cytometer (Millipore, Billerica, MA), and data
were analyzed and plotted with the use of FlowJo software
version n.6 (TreeStar Inc., Ashland, OR).The American Journal of Pathology - ajp.amjpathol.orgMorphology, Morphometry, and Biochemistry
At 7 months after CS exposure, the lungs of 8 of 10 mice
from each group were ﬁxed intratracheally with formalin
(5%) at a pressure of 20 cm H2O. Postﬁxation lung volume
was measured by water displacement. The lungs of mice
were then processed for histologic, morphometric, and
immunohistochemical analyses. Lung slices were stained
with hematoxylin and eosin, periodic acid-Schiff (PAS)
stain, and Masson trichrome. Assessment of emphysema
included mean linear intercept14 and internal surface area.15
The development of goblet cell metaplasia was evaluated by
PAS reaction.16,17
Quantiﬁcation of goblet cell metaplasia was performed on
PAS-stained lung sections from ﬁve mice from each group.
The number of PASþ cells in airways was determined by
examining eight intrapulmonary airways per section and
counting at least 3000 cells/section. Data were reported both
as the number of positive cells per millimeter of basement
membrane and as the percentage of positive cells per total
cells.
Peribronchiolar ﬁbrosis was quantitated in eight mouse
lungs from each group. The sea-green area of peribronchial
trichrome staining in parafﬁn-embedded lung was quantiﬁed
under a light microscope by point counting with the use of a
grid with 100 points, a 10 objective, and a computer
screen for a ﬁnal magniﬁcation of 820.
The sea-green area of the tissue section, A, was measured
with point counting as follows: AZ SP  a(p), where SP is
the number of points hitting tissue, and a(p) is the area asso-
ciated with each point in the counting grid [a(p)Z 900 mm2].
Results are expressed as the area of trichrome staining per
micrometer length of basement membrane of bronchioles
150 to 200 mm of internal diameter.
Tissue slides were analyzed independently by three
different observers. The slides were coded to prevent bias.
In addition ﬁve mice from each groups were used for
elastin determination, assessed as desmosine according to a
method previously described in detail.18 Similarly, addi-
tional samples taken from ﬁve lungs from each group and
stored in liquid nitrogen (at 80C) were used for mRNA
expression of perforin, granzyme B, IL-6, monocyte che-
moattractant protein 1, KC, and tumor necrosis factor-a.
Immunohistochemistry
Tissue sections (5 mm thick) were pretreated with 3%
hydrogen peroxide to inhibit the activity of the endogenous
peroxidases. For antigen retrieval, the sections were heated in
a microwave for 20 minutes in citrate buffer 0.01 mmol/L,
pH 6.0, and allowed to cool slowly to room temperature. The
slides were then incubated with 3% bovine serum albumin for
30 minutes at room temperature to block nonspeciﬁc anti-
body binding and then were exposed to primary antibodies
overnight at 4C. The following antibodies were used: rat
monoclonal anti-mouse to CD45R/B220 (dilution 1:20; BD1815
Table 1 Primers and Probes Used for Real-Time PCR
Gene name
(protein
name) Primers
Amplicon
length
(nt)
UPL
probe
Il6 F 50-TGCCTTCATTTATCCCTTGAA-30
R 50-TTACTACATTCAGCCAAAAAGCAC-30
63 #93
Mcp1 F 50-CATCCACGTGTTGGCTCA-30
R 50-GATCATCTTGCTGGTGAATGAGT-30
76 #62
Kc F 50-TGCTCAAGGCTGGTCCAT-30
R 50-GACATCGTAGCTCTTGAGTGTCA-30
86 #18
Tnfa F 50-CTGTAGCCCACGTCGTAGC-30
R 50-TTGAGATCCATGCCGTTG-30
97 #25
Pfn
(Perforin)
F 50-GAAGAAGAAACAGCACAAAATGG-30
R 50-GACGTGACGCTCACGGTAG-30
61 #31
Gzmb F 50-GCTGCTCACTGTGAAGGAAGT-30
R 50-TGGGGAATGCATTTTACCAT-30
107 #2
F, forward; R, reverse; UPL, Universal ProbeLibrary.
De Cunto et alPharmingen, Buccinasco, Italy), rat monoclonal anti-mouse
to CD4 (dilution 1:1000; Abcam, Cambridge, UK), rabbit
polyclonal Ab to myeloperoxidase (undiluted; Abcam), rat
monoclonal anti-mouse MAC-3 (dilution 1:20; (BD Phar-
mingen), rabbit polyclonal Ab to mouse inducible nitric oxide
synthase (iNOS; dilution 1:100; Abcam), and goat polyclonal
Ab to mouse eosinophil chemotactic factor-L (Chitinase;
dilution 1:250; R&D Systems Europe, LTD, Abingdon, UK).
For CD4, CD45R/B220, and MAC-3 detection, the
sections were rinsed and incubated with goat biotinylated
polyclonal Ab anti-rat IgG (dilution 1:100; Abcam) for 30
minutes at room temperature. The staining was revealed
by adding streptavidin-horseradish peroxidase (BD Phar-
mingen). Detection was accomplished by incubation in
diaminobenzidine freshly dissolved in 0.03% H2O2 in
50 mmol/L Tris/HCl, pH 7.6. As negative controls for the
immunostaining, the primary Ab was replaced by non-
immunized rat serum.
For iNOS and myeloperoxidase detection, sections were
rinsed and incubated with goat polyclonal Ab anti-rabbit
IgG (dilution 1:200); for eosinophil chemotactic factor-L
detection sections were rinsed and incubated with rabbit
polyclonal Ab anti-goat IgG (dilution 1:50; Sigma-Aldrich,
Indianapolis, IN). The staining was revealed by using the
immunoperoxidase method. As negative controls for the
immunostaining, the primary Ab was replaced by non-
immunized rabbit and goat serum.
The M.O.M. immunodetection kit (Vector Laboratories,
Burlingame, CA) was used for immunodetection of mouse
monoclonal Ab to CD8-a (dilution 1:100; Santa Cruz
Biotechnology Inc., Heidelberg, Germany) and mouse
monoclonal Ab to arginase I (dilution 1:100; BD Phar-
mingen). As negative controls for the immunostaining, the
primary Ab was replaced by nonimmunized serum.
Volume fractions of the immunopositive cells were
determined by point counting with the use of a grid with 48
points, a 20 objective.19 Twenty ﬁelds were examined for
each pair of lungs for a total of 960 points. The number of
points that fell on stained cells was divided by the total
number of points on the lung section. This number was then
multiplied by the volume of the lung corrected by the weight
of the mouse to give the total volume of the speciﬁcally
stained cells in the lung.20
The number of mice was eight in all groups.
RNA Isolation and cDNA Synthesis
Total RNA was extracted from lungs of mice at 7 months
after chronic exposure to room air or CS, using TRi Reagent
(Ambion, Austin, TX) according to the manufacturer’s in-
structions. Five mice for each group were used for RNA
isolation. RNA was resuspended in RT-PCR Grade Water
(Ambion), and the amount and purity of RNA were quan-
tiﬁed spectrophotometrically by measuring the optical den-
sity at 260 and 280 nm. Integrity was checked by agarose
gel electrophoresis.1816Two micrograms of total RNA was treated with TURBO
DNase (TURBO DNA-free kit; Ambion) for 30 minutes and
reverse transcribed with the RETROscript kit (Ambion)
according to the manufacturer’s instructions. Two hun-
dredths of the ﬁnal volume of reverse transcription was used
for real-time RT-PCR.
Real-Time RT-PCR
Real-time RT-PCR was performed in triplicate for each
sample on the MJ Opticon Monitor 2 (MJ Research Co.,
Waltham, MA) with speciﬁc locked nucleic acid probes
from the Mouse Universal ProbeLibrary Set (Roche, Indi-
anapolis, IN).
Primers were designed by using the free online Probe-
Finder software (available at the Universal ProbeLibrary
Assay Design Center, www.universalprobelibrary.com,
last accessed February 24, 2016) that shows a pair of
speciﬁc primers for each probe from the Universal
ProbeLibrary set (Table 1). PCR reactions were performed
in a volume of 25 mL and contained 12.5 mL of FastStart
TaqMan Probe Master (Roche), 300 nmol/L forward and
reverse primers (TIBMolbiol, Genova, Italy), 200 nmol/L
Universal ProbeLibrary probes, and 5 mL of cDNA.
Reactions were incubated at 95C for 10 minutes and then
ampliﬁed for 40 cycles, each cycle comprised of an
incubation step at 94C for 15 seconds, followed by 60C
for 1 minute. The real-time RT-PCR assay included a no-
template control and a standard curve of four serial dilution
points (in steps of 10-fold) of each of the test cDNAs. The
analysis of the results was based on the comparative cycle
threshold method (DDCt) in which Ct represents the cycle
number at which the ﬂuorescent signal, associated with an
exponential increase in PCR products, crosses a given
threshold. The average of the target gene was normalized
to 18S rRNA as the endogenous housekeeping gene.21
The combination of primers and probes provides speciﬁc
ampliﬁcation and detection of the target sequence in the
sample.ajp.amjpathol.org - The American Journal of Pathology
Figure 1 Flow cytometric analysis of lympho-
cytes from peripheral blood of WT or Lck/ mice
stained with the indicated surface markers. A:
Representative ﬂuorescence activated cell sorter
proﬁle of CD4/CD8 labeling of peripheral blood
from WT or Lck/ mice. B: Bar graphs showing
the percentage of CD4þ or CD8þ cells in peripheral
blood from WT or Lck/ mice. For each sample,
ﬂuorescence was analyzed on gated cells with
forward and side light scatter properties of lym-
phocytes. Data are expressed as means  SD. n 2
WT control and 5 Lck/ mice. **P < 0.01 Lck/
versus WT mice. WT, wild-type.
T Lymphocytes and Emphysema DevelopmentStatistical Analysis
Data are expressed as means  SD. The signiﬁcance of the
differences was calculated with one-way analysis of vari-
ance. A P value of <0.05 was considered signiﬁcant.Results
To assess the role of T cells in the development of smoking-
induced lung emphysema and airways remodeling, mice
with a severe reduction of peripheral T cells, namely Lck/
mice, were used. As previously reported10 Lck/ mice
developed a profound thymic atrophy that resulted in a
dramatic reduction of double positive (CD4þCD8þ) thy-
mocytes and in peripheral T cells (Figure 1).
The lungs of the mice from WT and Lck/ groups
exposed to room air for 7 months showed a well-ﬁxed
normal parenchyma with normal airways and wereThe American Journal of Pathology - ajp.amjpathol.orgvirtually indistinguishable from each other (Figure 2, A
and B). The lungs of mice from both genotypes exposed for
7 months to CS showed foci of emphysema disseminated
throughout the lung parenchyma (Figure 2, C and D). In
both phenotypes after CS exposure, the inﬂammation was
particularly evident in some ﬁelds and was characterized by
a moderate amount of polymorphonuclear and mononuclear
cell inﬁltrates in perivascular areas (Figure 3 A, B, E, and F)
and in peribronchiolar spaces (Figure 3 C, D, G and H).
Neutrophils and macrophages were observed throughout the
lung parenchyma and increased in both genotypes by
approximately 120% (116% in WT; 127% in Lck/ mice;
P < 0.01) and by approximately 125% (128% in WT; 123%
in Lck/ mice; P < 0.01), respectively (Figure 3, I and J).
Sparse and isolated T and B cells could be found in peri-
bronchial structure of WT mice after CS exposure
(Supplemental Figure S1, C, G, and K). Few T or B cells,
sparse or organized in lymphoid follicles, could be seen in
lung slices of smoking Lck/ mice (Supplemental Figure S1,Figure 2 Lung morphology. Representative
histologic sections from lungs of mice at 7 months
after air or CS exposure. A: WT mouse exposed to
air with a normal parenchyma. B: Lck/mouse
exposed to air with a normal parenchyma. C: WT
mouse showing after CS disseminated foci of
emphysema. D: Lck/ mouse showing after CS
evident areas of emphysema. Hematoxylin and
eosin staining. Scale bar Z 120 mm. CS, cigarette
smoke; WT, wild-type.
1817
Figure 3 Inﬂammatory cells in the lung of
smoking WT and Lck/ mice. Representative his-
tologic lung sections from Lck/ (AeD) and WT
(E and F) mice at 7 months after CS exposure. A:
Perivascular inﬁltrate of inﬂammatory cells in a
lung slide from a smoking Lck/ mouse. C: Peri-
bronchiolar inﬁltrates of polymorphonuclear and
mononuclear cells in a lung slide from a smoking
Lck/ mouse. B and D: Represent higher magni-
ﬁcation of areas delineated in white squares in
panels A and C, respectively. Perivascular (E) and
peribronchiolar (G) inﬂammatory cell inﬁltrates in
the lung slides from smoking WT mice. F and H:
Represent higher magniﬁcation of areas delineated
in white squares in panels E and G, respectively.
Hematoxylin and eosin staining. I: Neutrophil
volume density in the lung of WT or Lck/ mice
exposed either to room air or to CS for 7 months
after immunohistochemical reaction for myelo-
peroxidase. J: Macrophage volume density in the
lung of WT and or Lck/ mice exposed either to
room air or to CS for 7 months performed after
immunohistochemical reaction for macrophage
Mac-3. Data are presented as means  SD. n Z 8
mice in all groups. **P < 0.01 versus respective
air-exposed controls. Scale bar Z 120 mm. Air,
air exposure; CS, cigarette smoke; KO, knockout;
Smoke, CS-exposure; WT, wild-type.
De Cunto et alD, H, and L). A small number of CD4þ and CD8þ T cells
and B cells were found in lung slices from air-control mice of
both genotypes (Supplemental Figure S1, A, B, E, F, I,
and J). Volume fractions of T and B immunopositive cells
determined by point counting in lungs from control and
smoking mice of the different substrains are reported in
Figure 4, AeC. Tertiary lymphoid structures, containing1818germinal centers, were not present in lung parenchyma of air-
exposed and CS-exposed WT or Lck/ mice.
Morphometric evaluation of lung parenchyma conﬁrmed
that mice from both genotypes showed the same degree of
emphysematous lesions as revealed by mean linear in-
tercepts and internal surface area examination (Table 2). In
particular, chronic exposure to CS resulted in Lck/ miceajp.amjpathol.org - The American Journal of Pathology
Figure 4 A: Volume density of CD4þ T cells in the lung of WT and Lck/ mice exposed either to room air or to CS for 7 months. B: CD8þ T-cell volume
density in the lung of WT and Lck/ mice exposed either to room air or to CS for 7 months. C: B-cell volume density in the lung of WT and Lck/ mice exposed
either to room air or CS for 7 months. D: Quantitation of PASþ cells in airways from WT and Lck/ mice exposed either to room air or to CS for 7 months. The
number of cells per millimeter of basement membrane was determined. E: Trichrome-stained area. The analysis was performed on bronchioles 150 to 200 mm of
internal diameter. F: Volume density of iNOSþ (M1) and Chitinaseþ (M2) macrophages in the lung of WT and Lck/ mice exposed either to room air or to CS for
7 months. G: Real-time PCR analysis of mRNAs for IL-6, MCP-1, KC, TNF-a, perforin, and granzyme B performed on lungs from mice from each experimental
group at 7 months after CS exposure. Values are corrected for 18S rRNA and normalized to a median control value of 1.0. Data are presented as means  SD and
as values of sea-green area per micrometer length of basement membrane (E). nZ 8 mice in all groups (AeD and F); nZ 8 intrapulmonary airway/sections
(D); nZ 5 mice in each experimental group (E and G). **P < 0.01 versus respective air-exposed mice (A, B, D, and E); **P < 0.01 versus air-exposed mice of
the same genotype (C and F); **P < 0.01 compared with the median control value of 1.0 (G). yP < 0.05 versus smoke-exposed WT mice (A); yyP < 0.01 versus
smoke-exposed WT mice (B); zzP < 0.01 versus air-exposed WT mice (A and B). Air, air exposure; CS, cigarette smoke; iNOS, inducible nitric oxide synthase;
KO, knockout; MCP-1, monocyte chemotactic protein 1; PAS, periodic acid-Schiff; Smoke, CS exposure; TNF, tumor necrosis factor; WT, wild-type.
T Lymphocytes and Emphysema Developmentin a signiﬁcant increase of mean linear intercept values
(15%; P < 0.01) and in a signiﬁcant decrease of internal
surface area values (16%; P < 0.01). Similar results were
obtained in smoking WT mice. The results of the
biochemical analysis of lung desmosine content, expressed
as micrograms per lung, are also shown in Table 2. In miceThe American Journal of Pathology - ajp.amjpathol.orgfrom both genotypes chronically exposed to CS, lung levels
of desmosine were signiﬁcantly lower than those of air-
exposed controls (P < 0.01).
CS exposure for 7 months induced in WT and Lck/
mice the development of goblet cell metaplasia within the
epithelium of large- and middle-sized bronchi, as evident1819
Table 2 Lung Morphometry and Elastin (Determined as Desmosine) after Chronic Cigarette Smoke Exposure
Exposure
Lm (mm) ISA (cm2) Desmosine (mg/lung)
WT Lck/ WT Lck/ WT Lck/
Air 39.7  0.7 41.20  0.7 1212  72 1170  67 2.9  0.12 2.86  0.12
Smoke 46.4  1.2** 47.0  2.0** 1063  65** 938  55** 2.48  0.15** 2.45  0.14**
Data are presented as means  SD. n Z 8 and 5 mice for each group were used for morphometric and desmosine analysis, respectively.
**P < 0.01 versus air-control mice of the same strain.
ISA, internal surface area of lungs; Lm, mean linear intercept; WT, wild-type.
De Cunto et alafter PAS staining (Supplemental Figure S2, B and D). It is
well known that mice do not have goblet cells in their
bronchi (Supplemental Figure S2, A and C); thus, they are
considered to have goblet cell metaplasia when at least one
or more middle-sized bronchi/lung showed a positive PAS
staining.16 Quantiﬁcation of goblet cell metaplasia in the
different experimental groups is reported in Figure 4D, no
difference was observed between both genotypes chroni-
cally exposed to CS.
Bronchial or peribronchiolar regions showed an increased
collagen deposition (sea-green stain) in smoking WT and
Lck/ mice (Supplemental Figure S2, F and H). In some
areas from both genotypes an evident ﬁbrotic reaction was
seen (Supplemental Figure S2H). Only a small amount of
collagen was found around bronchioles and distal bronchi of
air-control mice of both substrains (Supplemental Figure S2,
E and G). The quantiﬁcation of sea-green areas performed by
point counting did not reveal a difference between the two
strains of mice at 7 months after CS exposure (Figure 4E).
Only few macrophages from air-exposed mice showed a
faint reaction for iNOS and Chitinase in lung slides from
air-exposed mice. The immunohistochemical reaction for
iNOS and Chitinase are reported in lung slides from air-
exposed Lck/ (Supplemental Figure S3, A and B,
respectively) and from WT mice (Supplemental Figure S3,
C and D, respectively).
WT mice exposed to CS showed in peripheral areas of the
lung a prevalence of M1 polarized macrophages, as detected
by immunohistochemical method for iNOS (Supplemental
Figure S3G). This immunoreaction was virtually absent in
air control WT mice (Supplemental Figure S3C). In the
same strain, macrophages with a prevalent M2 pattern of
activation were found after CS around bronchioles and
segmental bronchi as detected by a strong reaction for
Chitinase (Supplemental Figure S3H). Similar ﬁndings were
observed for Arginase 1 (data not shown).
A distribution and polarization similar to those observed
in WT mice were found in pulmonary macrophages of
smoking Lck/ mice (Supplemental Figure S3, E and F).
Volume fractions of M1 and M2 polarized macrophages
determined by point counting in lungs from smoking mice
of the different substrains are reported in Figure 4F.
The lung changes we observed in smoking mice at 7
months after CS exposure were accompanied by a signiﬁ-
cant increase of several proinﬂammatory cytokines such as
IL-6, monocyte chemoattractant protein 1, KC, and tumor1820necrosis factor-a. However, no signiﬁcant difference was
found between the two genotypes (Figure 4G). No differ-
ence among the various experimental groups was found in
the expression levels of perforin and granzyme B, the two
major cytolytic effector proteins of natural killer (NK) and
CD8 T cells (Figure 4G).Discussion
We report here that mice with a severe reduction of the
number of peripheral T cells and with a defective cell
function because of a targeted mutation of the Lck gene10,11
after chronic CS exposure develop emphysema and airways
changes similar to those observed in WT mice.13,16,17
Although COPD has been the subject of extensive inves-
tigation over the past decades, the mechanisms involved in
the pathogenesis of the disease are still the subject of debate.
These include protease/antiprotease and oxidant/antioxidant
imbalances, increased rate of epithelial cell apoptosis, and
abnormal innate or adaptive immune responses.22,23 CS is the
most important risk factor for the development of COPD, and
there are numerous reports on increased oxidative stress and
increased lung protease burden in smokers and in patients
with COPD.24e26 Several mechanisms were postulated as
to how proteases and/or oxidants can cause lung dys-
function.22e26 Protease/antiprotease and oxidant/antioxidant
imbalances may originate from innate and adaptive immune
responses of which many elements are abnormal in COPD.
Although the innate immune response has long been
considered important in the pathogenesis of COPD, reports
have underlined a potential role for T lymphocytes in the
inﬂammatory process that leads to COPD.6,27,28
Role for T Cells in Inducing Emphysema and Bronchial/
Bronchiolar Lesions after CS Exposure
An increased number of CD8 T cells with a potential
harmful capacity can be found in lungs of COPD
patients29e31 and mice chronically exposed to CS.32 On this
basis, it was assumed that an increase in the proin-
ﬂammatory and cytotoxic activity of CD8 T cells might
represent a key mechanism by which these cells contribute
to the pathophysiology of COPD.4,5 It was hypothesized
that CS induces activation of CD8 T cells, leading to pro-
duction of interferon-geinducible proteins that were shownajp.amjpathol.org - The American Journal of Pathology
T Lymphocytes and Emphysema Developmentto induce macrophage production of matrix metalloprotease-
12.33 Such a metalloprotease can degrade elastin, giving rise
to airspace enlargement.34
CD8 cells play an important role in autoimmune diseases
such as rheumatoid arthritis, systemic lupus erythematosus,
and diabetes mellitus.35 Autoreactive CD8 cells can drive
autoimmunity through cytotoxic activity that leads to tissue
destruction.36
Unfortunately, no direct or indirect evidence is available
in the literature to deﬁne COPD as an autoimmune disease
and at the current time, this hypothesis (the autoimmune
cause of COPD) is supported only by circumstantial evi-
dence because it is based only on the presence of inﬁltrating
mononuclear cells in the affected organ or tissue.37
Actually, no evidence can be found in literature to
recognize a direct role for T cells in inducing emphysema
and bronchial/bronchiolar lesions either by proteolysis or by
induction of apoptosis. Further support for such a view
derives from the results on perforin and granzyme B
expression that we present in the current study. In a recent
study Eppert et al38 reported that neither CD4 nor CD8
T-cell transfer from donor mice exposed to CS are alone
sufﬁcient to cause inﬂammation or pathologic characteris-
tics to CS-naive immunosufﬁcient mice. In addition, recip-
ient mice deﬁcient in major histocompatibility complex
(MHC) class I are protected from lung damage and
inﬂammation caused by T cells transferred from CS-
exposed mice. This study deﬁnes the requirement for both
CD4 and CD8 T cells from CS-exposed donor mice and
antigen presentation to CD8 T cells on MHC class I mole-
cules for transfer of airspace enlargements and inﬂamma-
tion.38 Unfortunately, the antigen(s) responsible for the
generation of autoreactive T cells in patients with COPD
and mouse models of COPD remain undeﬁned.
Reduction in Number and Function of T Cells Does Not
Confer Protection from CS-Induced Pulmonary Changes
The ﬁndings reported in our study are in agreement with
those reported by D’Hulst et al39 to indicate that Scid mice
are not protected from CS-induced emphysema and that
adaptive immune system is not required per se to induce
pulmonary emphysema after CS exposure. In Lck/ mice,
no biological relevant functions of T cells can be detected
because the reduced peripheral T cells present in these
mice are unable to respond to TCR-Ag-MHC activation.11
However, we cannot exclude that T cells in smoking
Lck/ mice are able to produce proinﬂammatory cytokines
also in the absence of TCR ligation.
Motz et al28 transferred CD3þ T cells puriﬁed from the
lungs of smoking mice into recipient mice knocked out for
Rag2 (Rag2/), a gene involved in the initiation of V(D)J
recombination during B- and T-cell development. After 13
weeks of exposure to CS or ﬁltered air, the recipient Rag2/
mice showed generation of pathogenic T cells that persis-
tently produce proinﬂammatory cytokines in the absence ofThe American Journal of Pathology - ajp.amjpathol.organtigen-dependent T-cell stimulation. These ﬁndings are in
agreement with the data reported in our study whose exper-
imental design (that includes speciﬁc methods to assess
COPD lesions) and ﬁndings complement that of Motz et al.28
These studies all together suggest that CD8 T cells may
contribute per se by means of antigen-independent mecha-
nism(s) to the onset and progression of COPD in patients
by production of proinﬂammatory cytokines28 that recruit
additional cell types to the inﬂamed tissue. An antigen-
independent activation of T cells may explain why the
results we found in smoking Lck/ mice in terms of
inﬂammation (increase in number of tissue neutrophils and
macrophages, increase in proinﬂammatory cytokine expres-
sion) and tissue destruction (positivity of morphometric end
points for COPD), are different from those reported by
Maeno et al6 in smoking CD8/ mice characterized by a
complete absence of CD8 T cells. The occurrence of a pop-
ulation of antigen-independent stimulated T cells may explain
also why our results in Lck/ mice after CS are similar to
those observed by Motz et al28 in WT and Rag2/ mice.
Our results are also in agreement with the observation of
D’Hulst et al39 that Scid mice develop inﬂammation and
emphysema after chronic CS exposure. The occurrence of
leakiness in Scid mice, which leads to the production of
some functional B and T cells may explain the CS-induced
emphysema in the study of D’Hulst et al.39 Another
explanation may be related to the presence of destructive
NK cells. However, no evidence for such a view is available
at the levels of perforin and granzyme B, the two major
cytolytic effector proteins of T cells and NK cells that did
not increase in the study of D’Hulst et al39 and in our study.
Moreover, no increased number of NK cells could be found
after CS exposure in smoking mice.40 These data all
together exclude a role for NK cells in inducing emphysema
and bronchial/bronchiolar lesions by perforin/granzyme
pathway.
Our data further support the conclusion reported by
Motz et al28 that CS can generate pathogenic CD8 T cells
capable of enhancing monocyte/macrophage and neutrophil
accumulation, inducing activation of proteases, and thus
contributing to degradation of extracellular matrix. The
absence of CD8 T cells in the lung of smoking mice may
offer an explanation as to why the results reported by Maeno
et al6 in terms of inﬂammation differ so markedly from
those reported in the current study and in the study by
Motz et al.28
Potential Role of Lymphocytes in Exacerbations
However, we cannot exclude that CD8 T cells in COPD
may play an important role in microbial exacerbations by
regulating macrophage accumulation and activation by
antigen-dependent mechanism(s). The presence of inﬁl-
trating T or B lymphocytes41e43 reported in lungs of some
patients with COPD may be related to pulmonary infections
which are not directly linked to the onset of the disease but1821
De Cunto et alto its progression. In this context, the marked abnormal lung
microbiome of some patients with advanced COPD likely
drives symptoms and contributes to exacerbation severity
and, thereby, mortality.41 Similarly in smoking models, the
increased number of T and B cells in lungs may be related to
concomitant infections when animals are maintained for a
long time in conventional manner (and not in barrier-
maintained environments).19 Actually, the role of CD8
cells in exacerbations is a matter of debate. A recent study
that dealt with immunoproteasome function in COPD shows
that its expression and activity are directly altered by CS
in vitro, in COPD patients, and in smoking mice. This re-
sults in disturbed MHC I antigen presentation and reduced
T-cell activation.44 In addition, it was recently found that
TCR components are down-regulated in pulmonary CD8
cells from COPD patients.45
Smoking Lck/ Mice Develop Chronic Lung
Inﬂammation
In conclusion, the ﬁndings reported in the current study
indicate that Lck/ mice exposed for 7 months to CS
develop a chronic inﬂammation and lung and airways
changes undistinguishable to those observed in WT mice
under the same experimental conditions. A reduced T-cell
antigen response in Lck/ mice is associated with an innate
immune response characterized by the accumulation of in-
ﬂammatory cells, predominantly in the form of neutrophils
and macrophages. Macrophage and neutrophil inﬂammation
results in the development of elastolytic emphysematous
lesions associated with consistent areas of goblet cell
metaplasia in bronchial and bronchiolar epithelium. In
addition, in the absence of a consistent T-cell response,
pulmonary macrophages of smoking Lck/ mice showed
within the lung parenchyma a prevalent M1 pattern of
activation and a high destructive potential.46 However,
pulmonary macrophages that are alternatively activated
(M2) are present in peribronchial and peribronchiolar areas.
The expression of Chitinase (and arginase) activity allows
these cells to participate in wound healing and scarring. The
different macrophage polarization that we observed in the
different anatomical regions may explain why emphysema
in smoking Lck/ mice is associated with a mild or mod-
erate ﬁbrotic reaction in some bronchial or peribronchiolar
areas.
These two different histopathologic features, namely
emphysema and airways remodeling, were also observed in
smoking WT mice. These changes may be regarded as two
different pathologic entities that resemble those observed in
pulmonary tissue from patients with COPD.
In our opinion, the neutrophil and macrophage accumu-
lation we observed in smoking mice from both genotypes
cannot be related to the occurrence of lung infections. In
fact, we did not observe an increase of neutrophils and
macrophages in lungs of air-exposed mice, which were
treated in the same fashion, in the same exposure chambers,1822and housed in the same environment and in the same con-
ditions of CS-exposed mice.
Generally, in infected mice lymphoid neogenesis occurs
and results in the formation of tertiary lymphoid structures
in lung parenchyma.41 Such lymphoid follicles that contain
germinal centers are not present in air-exposed and CS-
exposed WT or Lck/ mice, in which there is no alter-
ation in B-cell expansion and activation.
Conclusions
Collectively, our data indicate that targeted deletion of Lck
that leads to peripheral T cells unable to respond to TCR-
Ag-MHC activation and to a reduction in their number10
does not confer protection against the development of
emphysema and bronchial/bronchiolar remodeling induced
in mice by CS exposure.
Actually, studies in our and other laboratories strongly
suggest that innate inﬂammatory cells activated by different
stimuli on surface cell receptors are required to develop
pulmonary emphysema and airway remodeling in mice
chronically exposed to CS.47e52
However, the targeted deletion of Lck in mice does not
inﬂuence the expansion, maturation, and activation of B
cells. These cells are increased in lungs of smoking WT and
Lck/ mice under our experimental conditions. For these
reasons we cannot exclude a role, if any, in contributing to
the degree of lung changes in our model. Although the
ﬁndings reported by D’Hulst et al39 in smoking Scid mice
do not support a role for B cells in inducing emphysema,
recent data support a novel and convincing hypothesis that a
dysregulation of B cells contributes to COPD progression
that follows microbiome alteration.41e43
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